Loading insider details...
Latest Form 4 (Nov 10, 2026): Grant/Award of 100,000 SPRO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 10, 2026 | Spero Therapeutics, Inc. (SPRO) | Grant/Award | 100,000 | n/a |
| Jun 24, 2025 | RAPT Therapeutics, Inc. (RAPT) | Grant/Award | 75,000 | n/a |
| Feb 3, 2025 | RAPT Therapeutics, Inc. (RAPT) | Grant/Award | 450,000 | n/a |
| Nov 16, 2024 | RAPT Therapeutics, Inc. (RAPT) | Disposition to Issuer | 7,807 | n/a |
| Feb 2, 2024 | RAPT Therapeutics, Inc. (RAPT) | Grant/Award | 75,000 | n/a |
| Dec 22, 2023 | RAPT Therapeutics, Inc. (RAPT) | Sale | 2,500 | $54.2K |
| Nov 29, 2023 | RAPT Therapeutics, Inc. (RAPT) | Sale | 1,500 | $20.6K |
| Oct 4, 2023 | RAPT Therapeutics, Inc. (RAPT) | Sale | 2,500 | $39.4K |
| Aug 22, 2023 | RAPT Therapeutics, Inc. (RAPT) | Sale | 2,500 | $47.3K |
| Aug 3, 2023 | RAPT Therapeutics, Inc. (RAPT) | Exercise/Conversion | 460 | $5.5K |